Book a demo

Chemical intelligence powered by cypris.ai

Diallyl sulfone

3-prop-2-enylsulfonylprop-1-ene · also: allylsulfone, Allyl sulfone, diallyl sulphone, 3-allylsulfonyl-prop-1-ene, 3-(Allylsulfonyl)-1-propene, 1-Propene, 3,3'-sulfonylbis-

FormulaC6H10O2S
Mol. weight146.204
PubChem CID159797
InChIKeyNZEDMAWEJPYWCD-UHFFFAOYSA-N
SMILESC=CCS(=O)(=O)CC=C
8,969Patents
30Research papers
455Patents - last 3 years
0Papers - last 3 years

Who owns the IP

The organizations most actively patenting around this compound, ranked by referenced patent volume.

#AssigneePatents
1Merck Sharp & Dohme LLC208
2Pharmacyclics LLC175
3Bristol Myers Squibb Co153
4Fujifilm Corp149
5Eastman Kodak Co145
6Syensqo Specialty Polymers USA LLC126
7F Hoffmann La Roche AG114
8Astellas Pharma Inc98
9BASF SE97
10Novartis AG89

Explore the full landscape

This preview shows the leading assignees. Cypris reveals the full ownership landscape - every filing entity, filing trends, and portfolio momentum.

Visit Cypris

Where innovation is concentrated

Patent classifications ranked by volume reveal the technical domains with the most active filing.

#CodeAreaPatents
1A61PTherapeutic activity (drug indications)4,069
2C07DHeterocyclic compounds4,023
3A61KMedicinal preparations2,928
4C07CAcyclic and carbocyclic compounds1,002
5C08LPolymer compositions (blends)751
6C07KPeptides502
7C08GPolymers from non-vinyl bonds (e.g. polyamides, polyesters)439
8Y10TCross-reference (technical subjects)438
9C07FOrganometallic compounds403
10C08KPolymer compositions (additives)370

AI mapped opportunity space

This preview shows where patent activity concentrates. Cypris maps the full classification landscape to surface technical whitespace and IP headroom.

See Cypris in action

Most-cited patents

Patents ranked by forward citations reveal the foundational inventions the field continues to build on.

TitleYearAssigneeCited by
Peptidyl allyl sulfones2009Georgia Tech Research Corp12
Allyl sulfone compound and preparation method and application thereof2019NANJING TECH UNIVERSITY6
A kind of synthetic method of allyl sulfone2018GUANGDONG UNIVERSITY OF TECHNOLOGY3
Utilize the method for non-metallic catalyst selectivity synthesis allyl sulfone compound2017WUHAN INSTITUTE OF TECHNOLOGY2
PRODUCTION OF ALLYLSULFONE1988Kuraray Co Ltd2

Where research is gaining momentum

Research themes ranked by publication activity show where scientific interest is accelerating around this compound.

#Research topicPapers
1Garlic and Onion Studies1
2Tea Polyphenols and Effects1

Who's driving the science

The most-published authors working with this compound, alongside their primary affiliations.

#AuthorAffiliationPapers
1Poh‐Gek ForkertQueen's University13
2Chung S. YangRutgers, The State University of New Jersey8
3Jun‐Yan HongRutgers, The State University of New Jersey4
4Ashish SharmaQueen's University2
5Brandie MillenQueen's University2
6Burhan I. GhanayemNational Institutes of Health2
7Fang XiaoRutgers, The State University of New Jersey2
8Gordon P. BlackQueen's University2
9Jeanne M. GapacRutgers, The State University of New Jersey2
10John F. BradyRutgers, The State University of New Jersey2

Research leaders

This preview lists the top authors. Cypris surfaces the full researcher landscape, their affiliations, and how scientific influence is shifting.

See Cypris in action

The literature that defines it

The most-cited papers anchoring the scientific record for this compound.

Frequently asked questions

Common questions about this compound's patent and research landscape, answered from the underlying data.

What is the molecular composition of diallyl sulfone?

Diallyl sulfone has the molecular formula C6H10O2S with a molecular weight of 146.204. Its canonical IUPAC name is 3-prop-2-enylsulfonylprop-1-ene, and it is also known by several synonyms including allylsulfone and 3,3'-sulfonylbis(prop-1-ene).

Which organizations hold the most patents related to diallyl sulfone?

The leading patent assignees in this field are Merck Sharp & Dohme LLC with 208 patents, Pharmacyclics LLC with 175 patents, and Bristol Myers Squibb Co with 153 patents. Other significant patent holders include Fujifilm Corp, Eastman Kodak Co, and Syensqo Specialty Polymers USA LLC.

What research has been published on diallyl sulfone's biological effects?

Peer-reviewed research on this compound includes studies on inhibition of cytochrome P-450 2E1 by diallyl sulfide and its metabolites, mechanisms of inhibition of chemical toxicity and carcinogenesis by diallyl sulfide and related compounds from garlic, and modulation of rat hepatic microsomal monooxygenase enzymes. Notable highly-cited works include research on anticarcinogenic properties and radical photochemical reactions using allyl sulfone precursors.

What patent applications exist for synthesis and applications of allyl sulfones?

Patents on this compound include 'Peptidyl allyl sulfones' from Georgia Tech Research Corp (2009), 'Allyl sulfone compound and preparation method and application thereof' from Nanjing Tech University (2019), 'A kind of synthetic method of allyl sulfone' from Guangdong University of Technology (2018), and methods for selectivity synthesis using non-metallic catalysts from Wuhan Institute of Technology (2017). A production method was patented by Kuraray Co Ltd in 1988.

What is the scope of intellectual property activity for diallyl sulfone?

The compound has substantial IP coverage with 8,969 total patents across related chemical space and 455 patents filed in the last three years. The most commonly cited patent classification is A61P (pharmaceutical preparations) with 4,069 patents, followed by C07D (heterocyclic compounds) with 4,023 patents. Thirty peer-reviewed papers have been identified in the literature covering this compound.

Turn any compound into a complete chemical intelligence landscape

Go beyond static compound data. Cypris resolves identities, patents, papers, and commercial signals into one AI-powered view - so your team can move from a single chemical question to a complete R&D, IP, and market landscape.

Schedule a free trial